Delivery Order SPE2DB22D1202-SPE2DB25FVHQ9
Award Date 8/18/25
Potential Completion Date 8/19/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,024.38 firm fixed-price delivery order is for the supply of the medication BARHEMSYS 5 MG/2 ML VIAL 2ML. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,159.02, is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of January 9, 2024. The contract does not have a set-aside designation, indicating open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the pharmaceutical product BARHEMSYS 10 MG/4 ML VIAL 4ML, with a ceiling value of $3,263.93 and a period of performance through June 11, 2025. The contract is a firm fixed-price delivery order, indicating the agency has a defined requirement and has competitively awarded the order to AmerisourceBergen. As...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,215.41, is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567212297 - BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $1,310.68 and has a completion date of February 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a ceiling value of $28,487.26 and is a firm fixed price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication BARHEMSYS 10 MG/4 ML VIAL 4ML. The contract has a ceiling value of $5,316.04 and an ultimate completion date of April 22, 2025. This contract is not designated as a set-aside and represents an open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,207.10 contract is for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML, a medical product, with a period of performance through June 30, 2025. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award is for the pharmaceutical product BARHEMSYS 5 MG/2 ML VIAL 2ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,429.69 firm-fixed-price delivery order has a completion date of September 22, 2023 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- The Defense Logistics Agency awarded a delivery order valued at $4,500.70 to AmerisourceBergen Drug Corp for BARHEMSYS 5 mg/2 ml vials on August 3, 2025, with completion expected by August 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the awardee's facility in Conshohocken, Pennsylvania. BARHEMSYS (brexanolone) is an FDA-approved medication used to treat postpartum depression, reflecting the Defense Logistics Agency's role...